Wallimann, R.H.; Hensinger, H.; Müller, C.; Schibli, R.; Kneuer, R.; Schindler, P.
Liquid Chromatography ICP-MS to Assess the Stability of 175Lu- and natGa-Based Tumor-Targeting Agents towards the Development of 177Lu- and 68Ga-Labeled Radiopharmaceuticals. Pharmaceutics 2024, 16, 299.
https://doi.org/10.3390/pharmaceutics16030299
AMA Style
Wallimann RH, Hensinger H, Müller C, Schibli R, Kneuer R, Schindler P.
Liquid Chromatography ICP-MS to Assess the Stability of 175Lu- and natGa-Based Tumor-Targeting Agents towards the Development of 177Lu- and 68Ga-Labeled Radiopharmaceuticals. Pharmaceutics. 2024; 16(3):299.
https://doi.org/10.3390/pharmaceutics16030299
Chicago/Turabian Style
Wallimann, Rahel H., Heloïse Hensinger, Cristina Müller, Roger Schibli, Rainer Kneuer, and Patrick Schindler.
2024. "Liquid Chromatography ICP-MS to Assess the Stability of 175Lu- and natGa-Based Tumor-Targeting Agents towards the Development of 177Lu- and 68Ga-Labeled Radiopharmaceuticals" Pharmaceutics 16, no. 3: 299.
https://doi.org/10.3390/pharmaceutics16030299
APA Style
Wallimann, R. H., Hensinger, H., Müller, C., Schibli, R., Kneuer, R., & Schindler, P.
(2024). Liquid Chromatography ICP-MS to Assess the Stability of 175Lu- and natGa-Based Tumor-Targeting Agents towards the Development of 177Lu- and 68Ga-Labeled Radiopharmaceuticals. Pharmaceutics, 16(3), 299.
https://doi.org/10.3390/pharmaceutics16030299
